Gliclazide & Metformin Sustained Release Tablets 60/500mg Manufacturer & Supplier – PAN India Franchise by Taj Pharma

Trusted Gliclazide & Metformin 60/500mg Tablets Manufacturer from Mumbai & Vapi

Taj Pharma, a well-established pharmaceutical manufacturer from Vapi, Gujarat and Mumbai, Maharashtra, is a leading producer and global supplier of Gliclazide & Metformin Sustained Release Tablets 60/500mg, marketed under the brand name Claformin. With a legacy of excellence in diabetes management solutions, we are recognised for delivering high-quality, affordable, and WHO-GMP-compliant formulations to both domestic and international markets.

About Gliclazide & Metformin Sustained Release Tablets 60/500mg (Claformin)

Claformin 60/500mg is a fixed-dose combination of Gliclazide, a sulfonylurea, and Metformin, a biguanide, designed to treat Type 2 Diabetes Mellitus. This combination provides synergistic action by increasing insulin secretion and enhancing insulin sensitivity, effectively maintaining blood glucose levels and reducing HbA1c levels.

  • Gliclazide (60mg): Stimulates insulin secretion from the pancreas
  • Metformin HCl (500mg SR): Suppresses hepatic glucose production and increases peripheral glucose uptake

The sustained-release formulation ensures controlled drug release over time, reducing the frequency of dosing and enhancing patient compliance.

Advantages of Claformin 60/500mg Tablets

  • Dual mechanism of action for improved glycemic control
  • Sustained release technology ensures prolonged efficacy
  • Reduced risk of hypoglycemia compared to traditional sulfonylureas
  • Supports weight maintenance in diabetic patients
  • Decreases the likelihood of microvascular complications like neuropathy and retinopathy
  • Highly affordable compared to imported brands
  • Clinically proven and doctor-recommended therapy for Type 2 Diabetes

Certified Manufacturing Excellence at Taj Pharma

At Taj Pharma, our products are manufactured in state-of-the-art WHO-GMP, ISO 9001:2015, and GLP-certified facilities. Located in Vapi, Gujarat, our plants follow rigorous quality control processes, with each batch undergoing extensive QC and QA verification.

We meet all requirements for DCGI approval and provide export documentation support, including:

  • COPP, FSC, COA
  • Stability data
  • Bioequivalence and pharmacokinetics data
  • CTD/ACTD dossiers

PAN India PCD Pharma Franchise Opportunities for Gliclazide & Metformin Tablets

Taj Pharma offers a lucrative PCD Pharma Franchise for Gliclazide & Metformin 60/500mg Tablets (Claformin). Our franchise partners benefit from exclusive marketing rights, competitive prices, and top-tier support.

Benefits of Partnering with Taj Pharma:

  • Monopoly distribution rights in assigned territories
  • Free promotional tools (visual aids, LBLs, MR bags, pens, notepads)
  • High-profit margins and incentive programs
  • Dedicated marketing and customer service team
  • Real-time tracking and fast logistics

We are inviting distributors, wholesalers, and pharma professionals PAN India to associate with us and build a profitable business in the anti-diabetic segment.

Domestic and Global Reach

Taj Pharma supplies Claformin Tablets to major Indian cities including Mumbai, Ahmedabad, Delhi, Chennai, Hyderabad, Pune, Kolkata, and across all states and union territories.

Our global footprint extends to over 40 countries, including:

  • Africa: Nigeria, Tanzania, Ethiopia, South Africa
  • Middle East: UAE, Iraq, Saudi Arabia, Jordan
  • LATAM: Brazil, Peru, Colombia, Bolivia
  • CIS: Russia, Georgia, Kazakhstan, Ukraine
  • Asia Pacific: Vietnam, Philippines, Sri Lanka, Bangladesh

Our products are known for timely delivery, customised branding, and regulatory readiness for global market access.

Bulk Manufacturing & Third-Party Services for Claformin Tablets

Taj Pharma provides bulk manufacturing and third-party private label solutions for pharmaceutical companies, hospitals, and institutional buyers. Our flexibility in packaging sizes, formulations, and branding allows clients to grow their presence with a reliable manufacturing backbone.

We Offer:

  • Flexible batch sizes (trial to commercial scale)
  • Contract manufacturing with custom labelling
  • End-to-end regulatory and compliance documentation
  • Transparent pricing with no hidden costs
  • Strict timelines with guaranteed delivery

Our dedicated formulation development and regulatory team help partners quickly launch compliant products in competitive markets.

Dosage Guidelines & Safety Considerations

Usual Dosage:

  • One tablet daily with meals, or as prescribed by a physician.
  • Dosage may be adjusted based on glycemic response.

Contraindications:

  • Type 1 diabetes mellitus
  • Diabetic ketoacidosis
  • Severe renal or hepatic impairment
  • Pregnancy and lactation (use only with physician’s approval)

Precautions:

  • Monitor renal function and blood glucose regularly
  • Avoid alcohol to minimise lactic acidosis and hypoglycemia risks
  • Inform your doctor of any other medications being taken

Possible Side Effects:

  • Nausea, vomiting, diarrhoea
  • Hypoglycemia
  • Metallic taste
  • Skin reactions (rare)
  • Lactic acidosis (very rare, but serious)

Competitive Pricing & Custom Packaging Solutions

Taj Pharma offers competitive pricing structures with bulk discounts and custom branding options. Our blister packaging, bottle packing, and strip pack formats come in moisture-resistant, export-grade materials suitable for humid climates.

We support private labelling for pharmacies, distributors, and hospitals, enhancing your product visibility in local and international markets.

Why Choose Taj Pharma for Gliclazide & Metformin SR 60/500mg Tablets?

  • 40+ years of pharmaceutical excellence
  • Over 1500+ products approved by DCGI
  • Fully integrated R&D, production, and logistics support
  • Experience in catering to government tenders, NGOs, and institutional procurement
  • Robust cold chain and general logistics network
  • Global pharmaceutical licensing and product registration expertise

Our commitment to compliance, affordability, and quality makes us the first choice for leading pharma companies, hospitals, and healthcare organisations.